11-103399879-G-A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001080463.2(DYNC2H1):​c.12387+7G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.471 in 1,605,638 control chromosomes in the GnomAD database, including 180,693 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.51 ( 20164 hom., cov: 32)
Exomes 𝑓: 0.47 ( 160529 hom. )

Consequence

DYNC2H1
NM_001080463.2 splice_region, intron

Scores

2
Splicing: ADA: 0.00002362
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -1.20
Variant links:
Genes affected
DYNC2H1 (HGNC:2962): (dynein cytoplasmic 2 heavy chain 1) This gene encodes a large cytoplasmic dynein protein that is involved in retrograde transport in the cilium and has a role in intraflagellar transport, a process required for ciliary/flagellar assembly. Mutations in this gene cause a heterogeneous spectrum of conditions related to altered primary cilium function and often involve polydactyly, abnormal skeletogenesis, and polycystic kidneys. Alternative splicing results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, Jan 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 11-103399879-G-A is Benign according to our data. Variant chr11-103399879-G-A is described in ClinVar as [Benign]. Clinvar id is 302120.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-103399879-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.61 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
DYNC2H1NM_001080463.2 linkuse as main transcriptc.12387+7G>A splice_region_variant, intron_variant ENST00000650373.2 NP_001073932.1
DYNC2H1NM_001377.3 linkuse as main transcriptc.12366+7G>A splice_region_variant, intron_variant ENST00000375735.7 NP_001368.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
DYNC2H1ENST00000375735.7 linkuse as main transcriptc.12366+7G>A splice_region_variant, intron_variant 1 NM_001377.3 ENSP00000364887 P3Q8NCM8-1
DYNC2H1ENST00000650373.2 linkuse as main transcriptc.12387+7G>A splice_region_variant, intron_variant NM_001080463.2 ENSP00000497174 A1Q8NCM8-2

Frequencies

GnomAD3 genomes
AF:
0.511
AC:
77607
AN:
151962
Hom.:
20131
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.617
Gnomad AMI
AF:
0.398
Gnomad AMR
AF:
0.536
Gnomad ASJ
AF:
0.455
Gnomad EAS
AF:
0.529
Gnomad SAS
AF:
0.547
Gnomad FIN
AF:
0.432
Gnomad MID
AF:
0.528
Gnomad NFE
AF:
0.454
Gnomad OTH
AF:
0.495
GnomAD3 exomes
AF:
0.490
AC:
121112
AN:
247116
Hom.:
30362
AF XY:
0.487
AC XY:
65276
AN XY:
134030
show subpopulations
Gnomad AFR exome
AF:
0.620
Gnomad AMR exome
AF:
0.560
Gnomad ASJ exome
AF:
0.450
Gnomad EAS exome
AF:
0.535
Gnomad SAS exome
AF:
0.552
Gnomad FIN exome
AF:
0.417
Gnomad NFE exome
AF:
0.445
Gnomad OTH exome
AF:
0.471
GnomAD4 exome
AF:
0.467
AC:
678353
AN:
1453558
Hom.:
160529
Cov.:
30
AF XY:
0.469
AC XY:
339169
AN XY:
723522
show subpopulations
Gnomad4 AFR exome
AF:
0.629
Gnomad4 AMR exome
AF:
0.552
Gnomad4 ASJ exome
AF:
0.455
Gnomad4 EAS exome
AF:
0.564
Gnomad4 SAS exome
AF:
0.554
Gnomad4 FIN exome
AF:
0.414
Gnomad4 NFE exome
AF:
0.450
Gnomad4 OTH exome
AF:
0.481
GnomAD4 genome
AF:
0.511
AC:
77688
AN:
152080
Hom.:
20164
Cov.:
32
AF XY:
0.514
AC XY:
38212
AN XY:
74324
show subpopulations
Gnomad4 AFR
AF:
0.617
Gnomad4 AMR
AF:
0.537
Gnomad4 ASJ
AF:
0.455
Gnomad4 EAS
AF:
0.529
Gnomad4 SAS
AF:
0.545
Gnomad4 FIN
AF:
0.432
Gnomad4 NFE
AF:
0.454
Gnomad4 OTH
AF:
0.495
Alfa
AF:
0.467
Hom.:
5423
Bravo
AF:
0.518
Asia WGS
AF:
0.567
AC:
1973
AN:
3476
EpiCase
AF:
0.447
EpiControl
AF:
0.441

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 28, 2016Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -
Asphyxiating thoracic dystrophy 3 Benign:2
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 30, 2021- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
not provided Benign:1
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Jeune thoracic dystrophy Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Short rib-polydactyly syndrome Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.32
DANN
Benign
0.67

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000024
dbscSNV1_RF
Benign
0.0040
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs10895417; hg19: chr11-103270607; COSMIC: COSV62095911; COSMIC: COSV62095911; API